Clearer guidance on parallel imports of medicinal products

European Union

The CJEU’s decision in this case - together with the other decisions issued on 17 November 2022 - provides important guidance for trademark owners and parallel importers in the pharmaceutical industry.

Unlock unlimited access to all WTR content